Microfluidic Device Patent Landscape Report 2024

Microfluidic Device Market Size

The microfluidic device market was valued at USD 12.84 billion in 2023. It is expected to grow at a CAGR of 19.80% during the forecast period of 2024-2032 and attain a market value of USD 65.29 billion by 2032. Microfluidic device technology has revolutionized drug discovery, and diagnostic testing and the development of these advanced technologies including microfabrication. This has impacted the patent landscape.

Patent Landscape Report Coverage

The Microfluidic Device Patent Landscape report provides a comprehensive and in-depth analysis of the patents in the industry. The key sections captured in the report for microfluidic devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within microfluidic device technologies.

Microfluidic technology has multiple benefits as miniaturized devices allows processing and analyzing of small sample volumes, in the range of μL to pL. These devices exploit the physical and chemical properties of liquids and gases at a microscale level. Moreover, these devices allow the analysis and use of less volume of samples. These advancements in the field have led to increased patent filings by the companies to protect their intellectual property rights.

Microfluidic Device Patent Outlook

• The expanding applications of microfluidic device including diagnostics, drug delivery, point of care testing, DNA sequencing, among others has fueled the patent filings across multiple applications.

• The growing advancements in microfluidic technologies such as enhanced device design, development in fabrication technologies, and advanced fluid handling capabilities have led to increased patent filings to protect these technologies.

• The number of patent filings is increasing in several jurisdictions, particularly in the United States, and Europe. This surge can be attributed to healthcare companies, universities and academic institutions investing heavily in research to improve microfluidic device technologies.

What is a Microfluidic Device?

Microfluidic device involves the control and manipulation of fluids, within channels, typically ranging from tens to hundreds of micrometres in dimension. These devices are known for their small scale, which allows the handling of small amounts of fluids. This miniaturization offers advantages including faster reaction times, reduced reagent consumption, and increased sensitivity in analyses.

Microfluidic devices offer multiple benefits over conventionally sized systems. Microfluidics allow the analysis of less volume of samples, chemicals and reagents. The applications of microfluidic devices include separation and manipulation of cells, DNA analysis, nanoparticle transport in blood, diagnostics, and biopharmaceutical production among others. The development of innovative technologies for microfluidic systems promotes commercialization of microfluidic devices and patent filing of these advanced technologies.

Microfluidic Device Industry Growth Drivers

Advances in Microfabrication Techniques, such as Lithography, Micro-Electro-Mechanical Systems (MEMS) and 3D are Expected to Boost the Patent Industry Growth

Fluigent has developed a series of microfluidic systems based on its patented FASTAB technology. This technology overcomes the fluid volume manipulation issues which is present in current microfluidic control systems. This advanced technology features pressure driven flow control which allows a pulseless flow and greater responsiveness. Similarly, Dolomite Microfluidic Device has also launched an innovative 3D fluidics printer named Fluidic Factory. It is the first commercial 3D printer for fluidically sealed devices such as connectors, chips, fluid manifolds, valves, and medical devices. Companies are actively filing patents to protect their innovations which is significantly impacting the patent landscape.

Expanding Pharmaceutical and Biotechnology Applications Leading to a Rise in Patent Filing

The microfluidic device industry is growing due to expanding applications in pharma and biotech including point-of-care diagnostics, and drug delivery systems. Moreover, microfluidic platforms are used to detect biomarkers which are associated with various diseases. It facilitates early detection of disease and effective monitoring of treatment.

The research applications of microfluidic devices include the study of nanoparticle transport in blood and antibiotic drug-resistant bacteria. The expanding application signifies the need for patent registration. Companies are filing patents to protect inventions and impact the patent landscape. For instance, the number of patents granted increased from 5,511 in 2022 to 3552 in 2023.

Microfluidic Device Patent Segmentation

The report will cover the following sections in detail:

Breakup by Technology

• Lab-On-Chip

• Micro-Propulsion

• Micro-Thermal Technologies

• Organ-On-Chips

• Others

Microfluidic Device Patent Segmentation Analysis

The breakup based on technology includes lab-on-chip, micro-propulsion, micro-thermal technologies, organ-on-chips, and others. The production of microfluidic devices is achieved through multiple fabrication methods. The four most common techniques are soft lithography, 3D bioprinting, photolithography and injection moulding.

The detailed technological data will be provided for all specified segments classified in this report.

Microfluidic Device Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for microfluidic device patents, having around 90,000+ patents. The presence of an established legal framework and advanced research and development initiatives contribute to the patent landscape for the region.

Patent Profile of Key Companies

Among the players with microfluidic device patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Life Technologies Corp

Life Technologies Corporation, a ThermoFisher company founded in 2008, was formed by the merger of Invitrogen Corporation and Applied Biosystems Inc. The company holds several patents in the field of microfluidic devices.

Standard BioTools Inc.

Standard BioTools Inc. offers analytical mass cytometry systems for flow cytometry and tissue imaging. The company also offers associated assays and reagents, automated genomic analysis instruments and multiple microfluidic arrays. The company holds multiple patents related to microfluidic technologies. Their device includes a plurality of sets of first chambers and a plurality of sets of second chambers.

Other companies include Agilent Technologies Inc., and IBM, among others.

Reasons to Purchase this Report

The microfluidic device patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and also makes it understandable which companies have important patents in this field of microfluidic devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in the microfluidic device industry.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as microfluidic devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Microfluidic Device Patent Landscape Report

• Who are the key players in the microfluidic devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in microfluidic device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the microfluidic device industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in microfluidic devices?
• What are the challenges and opportunities in the microfluidic device patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in microfluidic devices?

Related Reports

Global Microfluidic Market

Global Microfluidic Device Market

Global In-Vitro Diagnostics Market

Global Bacterial Disease Diagnostics Market